Latest articles
Filters
articles
Weight Loss and Regain after Starting and Stopping GLP-1 Related Drugs
Several blogs on Knowing Diabetes describe the benefits of GLP-1 related drugs such as semaglutide (marketed as OzempicTM, RybelsusTM, or WegovyTM) and tirzepatide (marketed as MounjaroTM ,or ZepboundTM). Well-done research shows that these drugs improve glucose control, lower blood pressure, and reduce the chance of serious outcomes such as heart attacks and strokes. They also...
articles
What is An Evidence-Based Take?
When exploring the resources in the media library, you may notice videos that are called evidence-based takes (or EBTs). These cover a wide variety of topics including pregnancy and type 1 diabetes, type 2 diabetes remission, vaccinations and diabetes, diabetes and immunity, among others. An EBT is a short snippet from a conversation with a...
articles
Making Sense of Your Diabetes Lab Tests
After a routine appointment, your health care provider doctor hands you a requisition for a full panel of diabetes lab tests. These include HbA1c, creatinine, eGFR, LDL cholesterol, ALT, and a urine albumin-to-creatinine ratio. What does it all mean? While each test checks for something different, they are all designed to answer important questions about...
articles
What to Expect When Starting Semaglutide or Tirzepatide?
Semaglutide and tirzepatide are 2 drugs that are frequently used to manage type 2 diabetes. Semaglutide is marketed as either Ozempic or Wegovy and tirzepatide is marketed as either Mounjaro or Zepbound. They are excellent glucose lowering drugs and may also lower blood pressure. They also typically lower weight, reduce appetite and food cravings, with...
articles
Will My Children Inherit My Diabetes?
Diabetes is very common. Although its frequency varies with ancestry, an average of one of every nine or ten Canadians has diabetes. More than 90% of these people have type 2 diabetes, while less than 10% have type 1 diabetes. There is no question that genetics plays a role in the development of both types...
articles
Off-Label Use of Drugs Like Semaglutide and Tirzepatide in People With Type 1 Diabetes
The drugs semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (marketed as Mounjaro and Zepbound) are widely used to treat people with type 2 diabetes. Many large, well-done research studies of thousands of people have clearly shown that these drugs can improve glucose control, reduce the need for other glucose lowering drugs, and promote weight...

















